Claim and source comparison
Comparison scope: Abstracts of Hirsch 2017, Earnest 2004, Dai 2001, Huang 2001 and Hatton 2018. Not a complete clinical or independent medical review.
· Bounded source comparison; not a complete clinical review or independent medical endorsement.
Human randomized controlled trial
Hirsch 2017: In a randomized, double-blind trial, 28 people received 4 g/day of a mushroom blend containing Cordyceps militaris or placebo for one week. Time × treatment interactions for exercise outcomes were not significant at one week; only 10 continued to three weeks.
The small three-week subgroup and within-group changes do not replace the main one-week comparison. The blend is not pure Cordyceps; the trial does not establish cognitive benefit or equivalence of species.
Source 1 · Abstract read
Human randomized controlled trial
Earnest 2004: In a randomized, double-blind study of 17 cyclists, a multicomponent formula did not improve exercise performance over two weeks. Three capsules contained 1000 mg CS-4 and 300 mg Rhodiola plus other ingredients.
The negative blend result does not prove every Cordyceps product ineffective; capsule composition is not a personal regimen. Different fungi and extracts cannot be treated as equivalent by mass.
Source 2 · Abstract read
Animal study
Dai 2001: In male mice, seven days of CordyMax CS-4 extract at 200 or 400 mg/kg/day increased liver ATP measurements compared with placebo.
Mouse liver ATP is not human brain energy or clinical fatigue relief. The animal dose is not converted into a human dose; the abstract's clinical inference is not a direct human experiment.
Source 3 · Abstract read
Cell / laboratory study
Huang 2001: Cordyceps sinensis and some fractions increased progesterone production and, under some conditions, StAR protein in MA-10 mouse Leydig tumor cells.
This cell experiment does not establish human testosterone, fertility, immune or cognitive benefit. Culture-medium mg/mL values are not oral supplement doses.
Source 4 · Abstract read
Human case report / case review
Hatton 2018: Prolonged bleeding after dental surgery was reported in one person using Cordyceps sinensis daily.
One case does not establish causality, frequency or interaction with every blood thinner. Tell the clinical team about the product before surgery and when using medicines; these selected studies do not establish interactions with immunosuppressants. Missing records do not prove safety.
Source 5 · Abstract read
2026-11-11 correction: Selected sources were compared for study design, product, measured outcome and safety limits. Generic dosing and mechanism-to-benefit inferences were removed; the first-publication date was preserved.
Cordyceps species and different mushroom blends have been examined in exercise research. Human findings are limited and mixed; ATP and immune mechanisms alone do not establish improved clinical performance.
Clinical Trials
Hirsch 2017: In a randomized, double-blind trial, 28 people received 4 g/day of a mushroom blend containing Cordyceps militaris or placebo for one week. Time × treatment interactions for exercise outcomes were not significant at one week; only 10 continued to three weeks.
The small three-week subgroup and within-group changes do not replace the main one-week comparison. The blend is not pure Cordyceps; the trial does not establish cognitive benefit or equivalence of species.
Earnest 2004: In a randomized, double-blind study of 17 cyclists, a multicomponent formula did not improve exercise performance over two weeks. Three capsules contained 1000 mg CS-4 and 300 mg Rhodiola plus other ingredients.
The negative blend result does not prove every Cordyceps product ineffective; capsule composition is not a personal regimen. Different fungi and extracts cannot be treated as equivalent by mass.
Dai 2001: In male mice, seven days of CordyMax CS-4 extract at 200 or 400 mg/kg/day increased liver ATP measurements compared with placebo.
Mouse liver ATP is not human brain energy or clinical fatigue relief. The animal dose is not converted into a human dose; the abstract's clinical inference is not a direct human experiment.
Huang 2001: Cordyceps sinensis and some fractions increased progesterone production and, under some conditions, StAR protein in MA-10 mouse Leydig tumor cells.
This cell experiment does not establish human testosterone, fertility, immune or cognitive benefit. Culture-medium mg/mL values are not oral supplement doses.
Hatton 2018: Prolonged bleeding after dental surgery was reported in one person using Cordyceps sinensis daily.
One case does not establish causality, frequency or interaction with every blood thinner. Tell the clinical team about the product before surgery and when using medicines; these selected studies do not establish interactions with immunosuppressants. Missing records do not prove safety.
Dose information and research limits
This dose information describes research or product context; it is not a personal prescription, established safe upper limit or efficacy guarantee for healthy people. Extracts and different formulations should not be treated as equivalent milligram for milligram.
Related research and reading
These links show explicit editorial topic connections; they do not confirm a mechanism, efficacy or the safety of combined use. News dates refer to the source or event.
Educational guides
- Athlete Brain Performance: Supplement Evidence and Limits
Physical performance findings are not the same as cognitive benefits. Creatine, L-tyrosine, Rhodiola and caffeine studies are considered with their populations and conditions.
Sources
- Hirsch KR, et al. (2017). Cordyceps militaris improves tolerance to high-intensity exercise after acute and chronic supplementation. Journal of Dietary Supplements, 14(1), 42–53. PubMed · PMID 27408987
- Earnest CP, et al. (2004). Effects of a commercial herbal-based formula on exercise performance in cyclists. Medicine and Science in Sports and Exercise, 36(3), 504–509. PubMed · PMID 15076794
- Dai G, et al. (2001). CordyMax Cs-4 improves steady-state bioenergy status in mouse liver. Journal of Alternative and Complementary Medicine, 7(3), 231–40. https://doi.org/10.1089/107555301300328106 PubMed · PMID 11439844
- Huang BM, et al. (2001). Cordyceps sinensis and its fractions stimulate MA-10 mouse Leydig tumor cell steroidogenesis. Journal of Andrology, 22(5), 831–7. PubMed · PMID 11545297
- Hatton MN, et al. (2018). Excessive postextraction bleeding associated with Cordyceps sinensis: a case report and review of select traditional medicines used by Vietnamese people living in the United States. Oral surgery, oral medicine, oral pathology and oral radiology, 126(6), 494-500. PubMed · PMID 30195658
Link verification checks the identity of the publication; it does not constitute independent expert review of clinical claims. Our evidence and source methodology · Source directory
Frequently Asked Questions
Cordyceps species and different mushroom blends have been examined in exercise research. Human findings are limited and mixed; ATP and immune mechanisms alone do not establish improved clinical performance.
Hirsch 2017: In a randomized, double-blind trial, 28 people received 4 g/day of a mushroom blend containing Cordyceps militaris or placebo for one week. Time × treatment interactions for exercise outcomes were not significant at one week; only 10 continued to three weeks. The small three-week subgroup and within-group changes do not replace the main one-week comparison. The blend is not pure Cordyceps; the trial does not establish cognitive benefit or equivalence of species.
No established timeframe
Hatton 2018: Prolonged bleeding after dental surgery was reported in one person using Cordyceps sinensis daily. One case does not establish causality, frequency or interaction with every blood thinner. Tell the clinical team about the product before surgery and when using medicines; these selected studies do not establish interactions with immunosuppressants. Missing records do not prove safety.
Sale and import status in Türkiye must be checked for the specific product. Verify supplement approval in the Ministry of Agriculture and Forestry GGBS list, and medicine authorization and conditions of use in TİTCK records. Online availability does not establish approval or unrestricted personal import; current Ministry of Trade conditions apply to postal and express shipments.